SCHEMBL5011024

SCHEMBL5011024

c1ccc([C](Cc2cccc3ccccc23)c2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.63
CTNNB1 P35222 1/20 0.53
CYP1A2 P05177 3/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
ACP3 P15309 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
PTGER4 P35408 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP2D6 P10635 2/20 0.46
SIRT5 Q9NXA8 1/20 0.45
ATM Q13315 1/20 0.45
POLB P06746 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5010784 0.89 TDP1 (0.56) TDP1CTNNB1CYP1A2CYP2C19CYP2C9
SCHEMBL17435206 0.81 TDP1 (0.70) TDP1CTNNB1CYP1A2CYP2C19CYP2C9
SCHEMBL3245846 0.81 TDP1 (0.70) TDP1CTNNB1CYP1A2ACP3MEN1
SCHEMBL5008796 0.81 TDP1 (0.59) TDP1CTNNB1CYP1A2CYP2C19CYP2C9
SCHEMBL5013873 0.80 TDP1 (0.58) TDP1CYP1A2CYP2C19CYP2C9ACP3
SCHEMBL28007825 0.78 TDP1 (0.56) TDP1CTNNB1CYP1A2CYP2C19CYP2C9
SCHEMBL35925 0.78 TDP1 (1.00) TDP1CTNNB1CYP1A2ACP3MEN1
SCHEMBL29607554 0.78 TDP1 (1.00) TDP1CTNNB1CYP1A2ACP3MEN1
SCHEMBL9271599 0.78 TDP1 (0.66) TDP1CTNNB1CYP1A2CYP2C19CYP2C9
SCHEMBL28358062 0.78 TDP1 (0.66) TDP1CTNNB1CYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207864-A1 Organosilanes, Process For Production of the Same, and Use Thereof SHARP KABUSHIKI KAISHA (JP) 2008-08-28 US disclosed
EP-1641762-A2 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-04-05 EP disclosed
WO-2005005393-A2 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-01-20 WO disclosed